Author:
Momtazmanesh Sara,Rezaei Nima
Publisher
Springer International Publishing
Reference11 articles.
1. Bleesing JJ (2018) X-linked lymphoproliferative disease. In: UpToDate. UpToDate, Waltham. https://www.uptodate.com. Accessed 31 May 2019
2. Booth C, Gilmour KC, Veys P, Gennery AR, Slatter MA, Chapel H et al (2011) X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease. Blood 117(1):53–62
3. Engel P, Eck MJ, Terhorst C (2003) The SAP and SLAM families in immune responses and X-linked lymphoproliferative disease. Nat Rev Immunol 3(10):813–821
4. Fischer PA (2006) X-linked lymphoproliferative disease. Orphanet encyclopedia. https://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=2442. Accessed 30 May 2019
5. Gaspar HB, Sharifi R, Gilmour KC, Thrasher AJ (2002) X-linked lymphoproliferative disease: clinical, diagnostic and molecular perspective. Br J Haematol 119(3):585–595